Recent advances in exacerbations of COPD

Seemungal, Terence; Sykes, Annemarie
October 2008
Thorax;Oct2008, Vol. 63 Issue 10, p850
Academic Journal
The article offers information on the First International Conference on Exacerbations of Airways Disease (ICEAD), which discussion focuses on the management problems of exacerbations of both asthma and chronic obstructive pulmonary disease (COPD). An overview of the topics discussed is offered including respiratory viruses and the cause of airway bacterial infection.


Related Articles

  • Asthma: alternative anti-inflammatory agents needed for patient subgroup.  // PharmaWatch: Monthly Review;Mar2005, Vol. 4 Issue 3, p26 

    The article presents a study conducted by the European Network for Understanding Mechanisms of Severe Asthma, concerning the role of the neutrophil in the pathogenesis of asthma. It has suggested that severe asthma is a different disease to mild-moderate disease. The presence of neutrophilic...

  • Author's response: Airway anatomy in COPD: many dimensions to consider. Smith, Benjamin M.; Hoffman, Eric A.; Barr, R. Graham // Thorax;Jun2015, Vol. 70 Issue 6, p585 

    A response from the authors of the article related to multi-ethnic study of atherosclerosis (MESA) chronic obstructive pulmonary disease that was published in the 2014 issue of the periodical.

  • Editorial: Experimental models of asthma. Braun, Armin; Tschernig, Thomas; Groneberg, David A. // Journal of Occupational Medicine & Toxicology;2008, Vol. 3, Special section p1 

    Since 2002, a workshop entitled "Asthma in animal models" has been held once a year in Hannover, Germany. It is organized by the Fraunhofer Institute of Toxicology and Experimental Medicine in collaboration with the collaborative research centre "Sonderforschungsbereich" 587, "Immune reactions...

  • Continuing the debate about measuring asthma in population studies. Peat, J. K.; Toelle, B. G.; Marks, G. B.; Mellis, C. M. // Thorax;May2001, Vol. 56 Issue 5, p406 

    The reasons for measuring atopy and airway hyperresponsiveness (AHR) and the methods of validating measurements of in asthma in population studies continue to of be debated. The debate has centred around standards against which to validate asthma measurements but the absence of a "gold standard"...

  • Evaluation of airway inflammation by quantitative Th1 /Th2 cytokine mRNA measurement in sputum of asthma patients. Truyen, E.; Coteur, I.; Dilissen, E.; Overbergh, I.; Dupont, L. J.; Ceuppens, J. L.; Bullens, D. M. A. // Thorax;Mar2006, Vol. 61 Issue 3, p202 

    Background: Asthma is a chronic inflammatory disorder of the airways driven by I cell activation. Th2 cells and their cytokines are thought to play a role in the pathophysiology of allergic as well as non-allergic asthma. Methods: Airway cells were obtained by sputum induction from 15 healthy...

  • A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women. Lose, F.; Thompson, P. J.; Duffy, D.; Stewart, G. A.; Kedda, M.-A. // Thorax;Aug2005, Vol. 60 Issue 8, p623 

    Background: Airway remodelling is a characteristic feature of chronic asthma and there is evidence that an airway imbalance between levels of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinases-1 (TIMP-1) is associated with airway remodelling. On this basis, we...

  • Biopharmaceutical Therapeutics for Asthma Remodeling. Das, A. M.; Griswold, D. E.; Torphy, T. J.; Li, L. // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 25, p3233 

    Current asthma therapy is aimed at controlling disease symptoms. A subset of asthma patients remains symptomatic despite optimal therapy indicating that an unmet medical need exists for these patients. Innovative therapeutics are needed to treat the unmet need in asthma and biopharmaceutical...

  • Current Animal Models of Bronchial Asthma. Kurucz, I.; Szelenyi, I. // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 25, p3175 

    Human asthma is on the rise worldwide. The necessity to develop effective treatments against it requires an organized effort which covers every aspect of the disease from the pathological alterations via the genetic background to the use and development of active remedies. In these processes...

  • High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity. Little, S. A.; Sproule, M. W.; Cowan, M. D.; Macleod, K. J.; Robertson, M.; Love, J. G.; Chalmers, G. W.; McSharry, C. P.; Thomson, N. C. // Thorax;Mar2002, Vol. 57 Issue 3, p247 

    Background: In some patients chronic asthma results in irreversible airflow obstruction. High resolution computed tomography (HRCT) has been advocated for assessing the structural changes in the asthmatic lung and permits investigation of the relationships between airway wall thickening and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics